Medbanks Joins Up with IMS for China Oncology Big Data Effort

Medbanks, a Beijing oncology big data company, announced a strategic partnership with  IMS Health. In the collaboration, the two companies will establish and commercialize Medbanks' oncology-focused clinical database in China. Medbanks explained that cancer care, because of its complex and personalized nature, would be well served with a high-quality, structured clinical database, directed toward a China population. The information will guide clinical decision as well as research into novel drugs, improving outcomes. More details.... Share this with colleagues: // //